Blog
RSS FeedPosted by Michael Wonder on 25 Mar 2022
ATAGI statement on recommendations on a winter booster dose of COVID-19 vaccine
25 March 2022 - ATAGI recommends an additional booster dose of COVID-19 vaccine to increase vaccine protection before winter for ...
Posted by Michael Wonder on 24 Mar 2022
Leaked TRIPS proposal misguided about improving global COVID-19 vaccination rates
24 March 2022 - The leaked proposal on the waiver on intellectual property rights for COVID-19 vaccines is misguided and ...
Posted by Michael Wonder on 24 Mar 2022
Moderna finalises strategic partnership with Australian Government
23 March 2022 - On-shore manufacturing facility based in Melbourne, Australia, expected to produce up to 100 million mRNA respiratory ...
Posted by Michael Wonder on 24 Mar 2022
COVID-19 vaccine weekly safety report (24 March 2022)
24 March 2022 - To 20 March 2022, the TGA has received 485 reports which have been assessed as likely to ...
Posted by Michael Wonder on 21 Mar 2022
ATAGI update following weekly COVID-19 meeting (16 March 2022)
21 March 2022 - An update from the Australian Technical Advisory Group on Immunisation (ATAGI) following their weekly meeting on 16 ...
Posted by Michael Wonder on 17 Mar 2022
COVID-19 vaccine weekly safety report (17 March 2022)
17 March 2022 - To 13 March 2022, the TGA has received 457 reports which have been assessed as likely to ...
Posted by Michael Wonder on 11 Mar 2022
ATAGI update following weekly COVID-19 meeting (9 March 2022)
11 March 2022 - ATAGI have not made any new updates since 2 March 2022. ...
Posted by Michael Wonder on 10 Mar 2022
COVID-19 vaccine weekly safety report (10 March 2022)
10 March 2022 - To 6 March 2022, the TGA has received 460 reports which have been assessed as likely ...
Posted by Michael Wonder on 09 Mar 2022
TGA approves provisional determination for Biocelect for COVID-19 vaccine Nuvaxovid
10 March 2022 - The TGA has granted a second provisional determination to Biocelect (on behalf of Novavax) in relation ...
Posted by Michael Wonder on 07 Mar 2022
ATAGI update following weekly COVID-19 meeting (2 March 2022)
7 March 2022 - As of 1 March 2022, over 54 million doses of COVID-19 vaccines have been administered in ...
Posted by Michael Wonder on 03 Mar 2022
COVID-19 vaccine weekly safety report (3 March 2022)
3 March 2022 - This is the 52nd issue of the COVID-19 vaccine safety report. ...
Posted by Michael Wonder on 02 Mar 2022
ATAGI recommends Novavax for use as a COVID-19 booster
2 March 2022 - The Australian Technical Advisory Group on Immunisation has recommended the use of the Novavax vaccine as a ...
Posted by Michael Wonder on 28 Feb 2022
ATAGI update following weekly COVID-19 meeting (23 February 2022)
28 February 2022 - ATAGI recommends Spikevax (Moderna) COVID-19 vaccine can be used for primary vaccination in children aged 6-11 ...
Posted by Michael Wonder on 24 Feb 2022
COVID-19 vaccine weekly safety report (24 February 2022)
24 February 2022 - To 20 February 2022, the TGA has received 451 reports which have been assessed as likely to ...
Posted by Michael Wonder on 24 Feb 2022
ATAGI recommendations on the use of Spikevax (Moderna) COVID-19 vaccine in children aged 6 to 11 years
23 February 2022 - The Australian Technical Advisory Group on Immunisation (ATAGI) has made recommendations for the use of the Moderna ...